Our functional medicine team can help you look into anything that may be hindering your bodys own production of GLP-1 or causing GLP-1 resistance, and other factors that may be keeping you from feeling your best
That makes it impossible to determine whether the medications themselves are driving the improvements or whether those changes are happening because of downstream effects, such as weight loss, better blood sugar control, or changes in daily life
Key takeaways GLP-1 agonists are a class of drugs that were originally designed to treat type 2 diabetes, but their use has expanded to include weight loss, heart and kidney disease risk reduction, and management of obstructive sleep apnea
Back Holst, JJ, rskov,C, Schwartz, TW, et al (29 Aug 1986) 'Proglucagon 78-107, a potent insulinotropic hormone from lower smaller intestine', Diabetologia:Abstracts , 511A-610A.Back Holst, JJ, rskov, C, Vagn Nielsen, O, Schwartz, TW (1987) 'Truncated glucagon-like peptide I, an insulin-releasing hormone from the distal gut', FEBS letters , 211/2
Asymmetry and wound dehiscence may occur, particularly if the incision is under tension or an infection develops